David R. Schleifer

Vertrieb & Marketing bei Mitralign, Inc.

Health Technology

Consumer Services

Profil

David R.
Schleifer is currently the Vice President-Marketing at Mitralign, Inc. He previously worked as a Strategic Account Manager at Boston Scientific Corp.
Schleifer holds an MBA from Babson College and an undergraduate degree from Kenyon College.

Aktive Positionen von David R. Schleifer

Unternehmen	Position	Beginn
Mitralign, Inc. Mitralign, Inc. Medical SpecialtiesHealth Technology Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.	Vertrieb & Marketing	01.02.2016

Alle aktiven Positionen von David R. Schleifer

Ehemalige bekannte Positionen von David R. Schleifer

Unternehmen	Position	Ende
BOSTON SCIENTIFIC CORPORATION	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von David R. Schleifer im Detail an

Ausbildung von David R. Schleifer

Kenyon College	Undergraduate Degree
Babson College	Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von David R. Schleifer im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
BOSTON SCIENTIFIC CORPORATION	Health Technology

Private Unternehmen	1
Mitralign, Inc. Mitralign, Inc. Medical SpecialtiesHealth Technology Mitralign, Inc. operates as a valve repair company that engages in transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. The Mitralign Percutaneous Annuloplasty System, MPAS, is intended for the treatment of symptomatic functional mitral regurgitation for annular reduction through tissue plication. The company was founded by Paul A. Spence and Richard P. Geoffrion in 2003 and is headquartered in Tewksbury, MA.	Health Technology